Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways

Despite its clinical value, cisplatin (CISP) is complicated by marked hepatotoxicity via inducing oxidative stress, inflammatory, and apoptotic pathways. This study aims to explore the protective impact of azilsartan (AZIL), an antihypertensive drug, in addition to adipose tissue-derived mesenchymal...

Full description

Saved in:
Bibliographic Details
Main Authors: Amany Abdlrehim Bekhit, Olivia N. Beshay, Michael A. Fawzy, Sara Mohamed Naguib Abdel-Hafez, Gaber El-Saber Batiha, Farid S. Ataya, Moustafa Fathy
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2023/6767735
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547241925017600
author Amany Abdlrehim Bekhit
Olivia N. Beshay
Michael A. Fawzy
Sara Mohamed Naguib Abdel-Hafez
Gaber El-Saber Batiha
Farid S. Ataya
Moustafa Fathy
author_facet Amany Abdlrehim Bekhit
Olivia N. Beshay
Michael A. Fawzy
Sara Mohamed Naguib Abdel-Hafez
Gaber El-Saber Batiha
Farid S. Ataya
Moustafa Fathy
author_sort Amany Abdlrehim Bekhit
collection DOAJ
description Despite its clinical value, cisplatin (CISP) is complicated by marked hepatotoxicity via inducing oxidative stress, inflammatory, and apoptotic pathways. This study aims to explore the protective impact of azilsartan (AZIL), an antihypertensive drug, in addition to adipose tissue-derived mesenchymal stem cells (AD-MSCs) on CISP-induced hepatotoxicity. After characterization and labeling of AD-MSCs by PKH26 dye, 54 Wistar male albino rats were randomly divided into nine groups: I (CONT), II (AZIL.H), III (CISP), IV (CISP + AZIL.L), V (CISP + AZIL.H), VI (CISP + AD-MSCs), VII (CISP + AZIL.L + AD-MSCs), VIII (CISP + AZIL.H + AD-MSCs), and IX (CISP + VITA C). Serum alanine aminotransferase (ALT), alanine aminotransferase (AST), and albumin levels were determined. Assessment of reactive oxygen species, malondialdehyde, and glutathione contents, and superoxide dismutase activity and histopathological evaluations were done on hepatic tissue. Quantitative real-time PCR was utilized to estimate the expression of TNF-α and IL-6 genes. Cell homing of labeled AD-MSCs to the liver tissues was investigated. Hepatic expression of JNK1/2, ERK1/2, p38, Bax, Bcl-2, and cleaved caspase-3 proteins was investigated by western blot analysis. CISP elevated serum ALT and AST activities, reduced albumin level, and remarkably changed the hepatic architecture. It increased the expression TNF-α and IL-6 genes, raised the expression of JNK1/2, ERK1/2, p38, Bax, and cleaved caspase-3 proteins, and diminished the Bcl-2 protein. By contrast, treatment of animals with either AZIL or AD-MSCs dramatically reduced the effects of CISP injection. Moreover, treatment with combination therapy (AZIL.L or H + AD-MSCs) considerably mitigated all previously mentioned alterations superior to AZIL or AD-MSCs alone, which might be attributed to the AZIL-enhanced homing ability of AD-MSCs into the injured liver tissue. In conclusion, the present findings demonstrated that AZIL improves the hepatoprotective potential of AD-MSCs against CISP-induced hepatotoxicity by modulating oxidative stress, mitogen-activated protein kinase, and apoptotic pathways.
format Article
id doaj-art-9bfb25fdfb2e460681e905a7ae07c5c8
institution Kabale University
issn 1687-9678
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-9bfb25fdfb2e460681e905a7ae07c5c82025-02-03T06:45:38ZengWileyStem Cells International1687-96782023-01-01202310.1155/2023/6767735Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling PathwaysAmany Abdlrehim Bekhit0Olivia N. Beshay1Michael A. Fawzy2Sara Mohamed Naguib Abdel-Hafez3Gaber El-Saber Batiha4Farid S. Ataya5Moustafa Fathy6Department of BiochemistryDepartment of BiochemistryDepartment of BiochemistryDepartment of Histology and Cell BiologyDepartment of Pharmacology and TherapeuticsDepartment of BiochemistryDepartment of BiochemistryDespite its clinical value, cisplatin (CISP) is complicated by marked hepatotoxicity via inducing oxidative stress, inflammatory, and apoptotic pathways. This study aims to explore the protective impact of azilsartan (AZIL), an antihypertensive drug, in addition to adipose tissue-derived mesenchymal stem cells (AD-MSCs) on CISP-induced hepatotoxicity. After characterization and labeling of AD-MSCs by PKH26 dye, 54 Wistar male albino rats were randomly divided into nine groups: I (CONT), II (AZIL.H), III (CISP), IV (CISP + AZIL.L), V (CISP + AZIL.H), VI (CISP + AD-MSCs), VII (CISP + AZIL.L + AD-MSCs), VIII (CISP + AZIL.H + AD-MSCs), and IX (CISP + VITA C). Serum alanine aminotransferase (ALT), alanine aminotransferase (AST), and albumin levels were determined. Assessment of reactive oxygen species, malondialdehyde, and glutathione contents, and superoxide dismutase activity and histopathological evaluations were done on hepatic tissue. Quantitative real-time PCR was utilized to estimate the expression of TNF-α and IL-6 genes. Cell homing of labeled AD-MSCs to the liver tissues was investigated. Hepatic expression of JNK1/2, ERK1/2, p38, Bax, Bcl-2, and cleaved caspase-3 proteins was investigated by western blot analysis. CISP elevated serum ALT and AST activities, reduced albumin level, and remarkably changed the hepatic architecture. It increased the expression TNF-α and IL-6 genes, raised the expression of JNK1/2, ERK1/2, p38, Bax, and cleaved caspase-3 proteins, and diminished the Bcl-2 protein. By contrast, treatment of animals with either AZIL or AD-MSCs dramatically reduced the effects of CISP injection. Moreover, treatment with combination therapy (AZIL.L or H + AD-MSCs) considerably mitigated all previously mentioned alterations superior to AZIL or AD-MSCs alone, which might be attributed to the AZIL-enhanced homing ability of AD-MSCs into the injured liver tissue. In conclusion, the present findings demonstrated that AZIL improves the hepatoprotective potential of AD-MSCs against CISP-induced hepatotoxicity by modulating oxidative stress, mitogen-activated protein kinase, and apoptotic pathways.http://dx.doi.org/10.1155/2023/6767735
spellingShingle Amany Abdlrehim Bekhit
Olivia N. Beshay
Michael A. Fawzy
Sara Mohamed Naguib Abdel-Hafez
Gaber El-Saber Batiha
Farid S. Ataya
Moustafa Fathy
Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
Stem Cells International
title Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
title_full Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
title_fullStr Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
title_full_unstemmed Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
title_short Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
title_sort curative effect of ad mscs against cisplatin induced hepatotoxicity in rats is potentiated by azilsartan targeting oxidative stress mapk and apoptosis signaling pathways
url http://dx.doi.org/10.1155/2023/6767735
work_keys_str_mv AT amanyabdlrehimbekhit curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT olivianbeshay curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT michaelafawzy curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT saramohamednaguibabdelhafez curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT gaberelsaberbatiha curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT faridsataya curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways
AT moustafafathy curativeeffectofadmscsagainstcisplatininducedhepatotoxicityinratsispotentiatedbyazilsartantargetingoxidativestressmapkandapoptosissignalingpathways